Domzalski David (CIK 1727794) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Sell VYNE (12,214 shares), Buy VYNE (30,791 shares), Sell VYNE (14,232 shares), Sell VYNE (12,684 shares), Sell VYNE (12,676 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Sell | 12,214 | $7,948 |
| 2026-06-02 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Buy | 30,791 | $9,545 |
| 2026-04-02 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Sell | 14,232 | $8,504 |
| 2026-01-05 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Sell | 12,684 | $7,357 |
| 2025-10-02 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Sell | 12,676 | $4,310 |
| 2025-07-02 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Sell | 12,676 | $20,915 |
| 2025-06-03 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Buy | 8,681 | $7,032 |
| 2025-04-02 | VYNE Therapeutics Inc. (VYNE) | PRESIDENT AND CEO | Sell | 30,498 | $48,187 |
Source: SEC Form 4 filings · as of 2026-07-02